Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ullum

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Scandinavian Journal of Immunology|September 14, 2001
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, M Von Essen, P Schjerling, et al.
Scandinavian Journal of Immunology|May 20, 2003
T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppressionH Aladdin, T Katzenstein, A-M Dreves, et al.
Scandinavian Journal of Immunology|June 13, 2006
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapyS R Ostrowski, T L Katzenstein, M Pedersen, et al.
The Journal of Infectious Diseases|February 18, 1998
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progressionH Ullum, A Cozzi Lepri, J Victor, et al.
The Journal of Infectious Diseases|June 1, 1997
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjectsH Ullum, J Victor, T L Katzenstein, et al.
Scandinavian Journal of Immunology|March 18, 2000
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patientsH Aladdin, C S Larsen, B K Møller, et al.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
AIDS Research and Human Retroviruses|August 10, 1997
Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individualsH Ullum, A Cozzi Lepri, K Bendtzen, et al.
Parasite Immunology|December 26, 2006
Elevated plasma urokinase receptor predicts low birth weight in maternal malariaS R Ostrowski, C E Shulman, N Peshu, et al.
International Journal of Sports Medicine|March 1, 1997
Exercise-induced immunomodulation--possible roles of neuroendocrine and metabolic factorsB K Pedersen, H Bruunsgaard, M Klokker, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Scandinavian Journal of Immunology|September 14, 2001
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, M Von Essen, P Schjerling, et al.
Scandinavian Journal of Immunology|May 20, 2003
T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppressionH Aladdin, T Katzenstein, A-M Dreves, et al.
Scandinavian Journal of Immunology|June 13, 2006
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapyS R Ostrowski, T L Katzenstein, M Pedersen, et al.
The Journal of Infectious Diseases|February 18, 1998
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progressionH Ullum, A Cozzi Lepri, J Victor, et al.
The Journal of Infectious Diseases|June 1, 1997
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjectsH Ullum, J Victor, T L Katzenstein, et al.
Scandinavian Journal of Immunology|March 18, 2000
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patientsH Aladdin, C S Larsen, B K Møller, et al.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
AIDS Research and Human Retroviruses|August 10, 1997
Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individualsH Ullum, A Cozzi Lepri, K Bendtzen, et al.
Parasite Immunology|December 26, 2006
Elevated plasma urokinase receptor predicts low birth weight in maternal malariaS R Ostrowski, C E Shulman, N Peshu, et al.
International Journal of Sports Medicine|March 1, 1997
Exercise-induced immunomodulation--possible roles of neuroendocrine and metabolic factorsB K Pedersen, H Bruunsgaard, M Klokker, et al.
Pageof 8